EnteroMedics (ETRM) : During the past 4 weeks, traders have been relatively bearish on EnteroMedics (ETRM), hence the stock is down -42.76% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -15.74% relative to the S&P 500. The 4-week change in the price of the stock is -38.89% and the stock has fallen -15.22% in the past 1 week.
EnteroMedics (NASDAQ:ETRM): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $0.21 and $0.20 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $0.24. The buying momentum continued till the end and the stock did not give up its gains. It closed at $0.22, notching a gain of 6.28% for the day. The total traded volume was 2,309,250 . The stock had closed at $0.21 on the previous day.
The stock has recorded a 20-day Moving Average of 25.87% and the 50-Day Moving Average is 49.98%. EnteroMedics Inc. has dropped 75.82% during the last 3-month period . Year-to-Date the stock performance stands at -88.72%.
EnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Companys neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve using high frequency, low energy, electrical impulses. The Companys initial product is the Maestro System, which uses VBLOC therapy to affect metabolic regulatory control, limits the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company has approvals to commercially launch its product, the Maestro Rechargeable System, in the United States, Australia, the European Economic Area and other countries.